Literature DB >> 20832361

Basic and translational applications of engineered MHC class I proteins.

Ted H Hansen1, Janet M Connolly, Keith G Gould, Daved H Fremont.   

Abstract

Major histocompatibility complex (MHC) class I molecules can be engineered as single chain trimers (SCTs) that sequentially incorporate all three subunits of the fully assembled proteins, namely peptide, β2 microglobulin, and heavy chain. SCTs have been made with many different MHC-peptide complexes and are used as novel diagnostic and therapeutic reagents, as well as probes for diverse biological questions. Here, we review the recent and diverse applications of SCTs. These applications include new approaches to enumerate disease-related T cells, DNA vaccines, eliciting responses to pre-assembled MHC-peptide complexes, and unique probes of lymphocyte development and activation. Future applications of SCTs will be driven by their further engineering and the ever-expanding identification of disease-related peptides using chemical, genetic and computational approaches.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832361      PMCID: PMC2949479          DOI: 10.1016/j.it.2010.07.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  56 in total

1.  Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma.

Authors:  J White; F Crawford; D Fremont; P Marrack; J Kappler
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

2.  Flow cytometry applications of MHC tetramers.

Authors:  John D Altman
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

3.  An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.

Authors:  Mark D Crew; Martin J Cannon; Bounleut Phanavanh; Carmen N Garcia-Borges
Journal:  Mol Immunol       Date:  2005-01-08       Impact factor: 4.407

4.  Creating CTL targets with epitope-linked beta 2-microglobulin constructs.

Authors:  R A Uger; B H Barber
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

5.  The repertoire of T cells shaped by a single MHC/peptide ligand.

Authors:  L Ignatowicz; J Kappler; P Marrack
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

6.  Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.

Authors:  André Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

7.  Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression.

Authors:  G R Otten; E Bikoff; R K Ribaudo; S Kozlowski; D H Margulies; R N Germain
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

8.  Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.

Authors:  K Toshitani; V Braud; M J Browning; N Murray; A J McMichael; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.

Authors:  M G Mage; L Lee; R K Ribaudo; M Corr; S Kozlowski; L McHugh; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

Authors:  A Porgador; K R Irvine; A Iwasaki; B H Barber; N P Restifo; R N Germain
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  18 in total

1.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

2.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

3.  Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.

Authors:  Dibyendu Samanta; Gayatri Mukherjee; Udupi A Ramagopal; Rodolfo J Chaparro; Stanley G Nathenson; Teresa P DiLorenzo; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 4.  Donor-unrestricted T cells in the human CD1 system.

Authors:  Shouxiong Huang; D Branch Moody
Journal:  Immunogenetics       Date:  2016-08-09       Impact factor: 2.846

5.  Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells.

Authors:  Ben C King; Angela D Hamblin; Philip M Savage; Leon R Douglas; Ted H Hansen; Ruth R French; Peter W M Johnson; Martin J Glennie
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

6.  Amino-terminal extended peptide single-chain trimers are potent synthetic agonists for memory human CD8+ T cells.

Authors:  Beatriz M Carreno; Michelle Becker-Hapak; Megan Chan; Wen-Rong Lie; Xiaoli Wang; Ted H Hansen; Gerald P Linette
Journal:  J Immunol       Date:  2012-05-09       Impact factor: 5.422

7.  HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities.

Authors:  Hongbing Yang; Margarida Rei; Simon Brackenridge; Elena Brenna; Hong Sun; Shaheed Abdulhaqq; Michael K P Liu; Weiwei Ma; Prathiba Kurupati; Xiaoning Xu; Vincenzo Cerundolo; Edward Jenkins; Simon J Davis; Jonah B Sacha; Klaus Früh; Louis J Picker; Persephone Borrow; Geraldine M Gillespie; Andrew J McMichael
Journal:  Sci Immunol       Date:  2021-03-25

8.  The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.

Authors:  Helen L Wu; Roger W Wiseman; Colette M Hughes; Gabriela M Webb; Shaheed A Abdulhaqq; Benjamin N Bimber; Katherine B Hammond; Jason S Reed; Lina Gao; Benjamin J Burwitz; Justin M Greene; Fidel Ferrer; Alfred W Legasse; Michael K Axthelm; Byung S Park; Simon Brackenridge; Nicholas J Maness; Andrew J McMichael; Louis J Picker; David H O'Connor; Scott G Hansen; Jonah B Sacha
Journal:  J Immunol       Date:  2017-11-17       Impact factor: 5.422

9.  Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Authors:  Scott G Hansen; Helen L Wu; Benjamin J Burwitz; Colette M Hughes; Katherine B Hammond; Abigail B Ventura; Jason S Reed; Roxanne M Gilbride; Emily Ainslie; David W Morrow; Julia C Ford; Andrea N Selseth; Reesab Pathak; Daniel Malouli; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Geraldine M Gillespie; Lucy C Walters; Simon Brackenridge; Hannah R Sharpe; César A López; Klaus Früh; Bette T Korber; Andrew J McMichael; S Gnanakaran; Jonah B Sacha; Louis J Picker
Journal:  Science       Date:  2016-01-21       Impact factor: 47.728

Review 10.  T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy.

Authors:  Zhijian Duan; Mitchell Ho
Journal:  Mol Cancer Ther       Date:  2021-06-25       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.